PHASE4 VENTURES
Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US and Europe. Founded in 1999, the team has made close to 30 investments in Life Science companies alongside other top tier venture capital firms in both Europe and the US. The team is complemented by an extensive group of advisors with operating experience at a senior level in pharmaceutical and biotechnology companies. Phase4 Ventures' investments include many of the compa... nies that have provided successful European and US venture exits including Intercell, Pharmion, Targacept and most recently Proteolix. Phase4 Ventures was spun-out from Nomura in December 2010 following a buy out of the management company by the team and a secondary purchase of a fund by HarbourVest Partners. Phase4 Ventures currently manages funds for both Nomura and HarbourVest. Phase4 Ventures Limited is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).
PHASE4 VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Closed
Contact:
44 203 036 0050
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2009-08-06 | Zosano Pharma | Phase4 Ventures investment in Series B - Zosano Pharma | 30 M USD |
| 2008-11-04 | OncoMed Pharmaceuticals | Phase4 Ventures investment in Series B - OncoMed Pharmaceuticals | 154 M USD |
| 2008-09-08 | Proteolix | Phase4 Ventures investment in Series C - Proteolix | 79 M USD |
| 2007-11-15 | Zosano Pharma | Phase4 Ventures investment in Series A - Zosano Pharma | 90 M USD |
| 2007-09-04 | Nabriva Therapeutics | Phase4 Ventures investment in Venture Round - Nabriva Therapeutics | 56 M USD |
| 2007-03-08 | Phenomix | Phase4 Ventures investment in Series C - Phenomix | 55 M USD |
| 2006-04-03 | Chroma Therapeutics | Phase4 Ventures investment in Series C - Chroma Therapeutics | 53 M USD |
| 2006-02-10 | ARYx Therapeutics | Phase4 Ventures investment in Series E - ARYx Therapeutics | 30.4 M USD |
| 2005-10-26 | Cerimon Pharmaceuticals | Phase4 Ventures investment in Series A - Cerimon Pharmaceuticals | 70 M USD |
| 2004-06-01 | ARYx Therapeutics | Phase4 Ventures investment in Series D - ARYx Therapeutics | 55 M USD |
More informations about "Phase4 Ventures"
Phase4 Partners - Crunchbase Investor Profile & Investments
Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures, has more recently expanded its mission to …See details»
Phase4 Ventures - Investments, Portfolio & Company Exits
Aug 6, 2009 Phase4 Ventures 's most notable exits include Zosano Pharma, Nabriva Therapeutics, and OncoMed Pharmaceuticals. Which industries has this organization had the …See details»
Phase4 Ventures - Products, Competitors, Financials, Employees ...
Phase4 Ventures Spins Out from Nomura and Partners with HarbourVest to Acquire a Portfolio of Investments – HarbourVest. Mar 24, 2017. Phase4 Ventures Spins Out from Nomura and …See details»
Venture Capital Funding in the Life Sciences: Phase4 Ventures – A …
Jun 12, 2014 Venture Capital Funding in the Life Sciences: Phase4 Ventures – A Case Study Reporter: Aviva Lev-Ari, PhD, RN SOURCE Long known as one of the leading life science …See details»
Phase4 Ventures III: Fund Performance - PitchBook
Dec 31, 2011 Phase4 Ventures III's latest investment was on 03-Nov-2016 in Albireo, a company within the Biotechnology industry. Data Transparency. Meet our data hygiene team. …See details»
Phase4 Partners | Institution Profile - Private Equity International
Phase4 Partners News, insights, analysis and data Founded in 1999, Phase4 Partners (formerly known as Phase4 Ventures), was a London-based private equity firm that specialises in early …See details»
Phase4 Ventures spins out from Nomura - Private Equity Wire
Feb 9, 2011 Since 1999 the Phase4 Ventures team has made more than 30 investments in mid-to-late stage life science companies alongside other top tier venture capital firms in both the …See details»
Phase4 Ventures spins out from Nomura and partners with …
Phase4 Ventures will manage the new fund, Phase4 Ventures III LP, for HarbourVest, and an existing fund for Nomura. The company and its eight-strong team, led by Dr Denise Pollard …See details»
Nomura Spins Off Phase4 Ventures - Institutional Investor
Feb 9, 2011 Phase4 Ventures will run the new fund, Phase4 Ventures III, for HarbourVest and an existing fund for Nomura. The firm and its team, led by Denise Pollard-Knight , will continue …See details»
Macroflux Corporation Nomura Phase4 Ventures - Nomura Holdings
Nomura Phase4 Ventures Limited is authorised and regulated by the FSA. Contact The Macroflux Corporation Dr Judy Hemberger CEO, The Macroflux Corporation Tel: +1-650 404.1235 …See details»
Phase4 VC spins out of Nomura with increased European focus
European biotech and medtech companies will be a primary focus for Phase4 Ventures, the life sciences venture capital business that has just been acquired by its management team from …See details»
Phase4 Partners - Investments, Portfolio & Company Exits
Aug 7, 2020 Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures, Search Crunchbase Start …See details»
ASTRAZENECA AND NOMURA PHASE4 VENTURES ANNOUNCE
About Nomura Phase4 Ventures Nomura Phase4 Ventures is an active global life science investor whose mission is to provide a premium rate of return for investors by creating, identifying and …See details»
Charles S. - General Counsel And Business Development. Co
Before joining Phase4 Partners, Charles held various roles at Nomura, including Partner of Nomura Phase4 Ventures from January 2004 to December 2010 and Associate Director from …See details»
AstraZeneca and Nomura Phase4 Ventures Announce Creation of …
Feb 15, 2008 AstraZeneca and Nomura Phase4 Ventures announced the signing of a deal to form Albireo, a company focused on developing new treatments for gastrointestinal (GI) …See details»
Phenomix pockets $55M in third round | Fierce Biotech
Mar 7, 2007 San Diego-based Phenomix has raised $55 million in its third round of venture financing. Nomura Phase4 Ventures led the financing with JP Morgan Partners, Delphi …See details»
Naveed Siddiqi - Partner, Novo Ventures at Novo Holdings - The …
Naveed Siddiqi is a Partner at Novo Ventures, a venture capital firm that invests in healthcare companies. Prior to joining Novo Ventures, Siddiqi was a Partner at Phase4 Ventures, where …See details»
Phase Four raises $26 million - SpaceNews
Jun 11, 2021 Phase Four was introduced to New Science Ventures through another investor, he said. That VC firm has previously invested in ABL Space Systems, a small launch vehicle …See details»
Phase4 Partners - Contacts, Employees, Board Members
Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures,See details»
Nonprofit 1863 Ventures has closed, reborn into for-profit New …
2 days ago The nonprofit organization 1863 Ventures, which focused on providing capital and mentorship to early-staged underrepresented founders, will close and become a for-profit …See details»